Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding

IMPORTANCE: Many patients with nonvalvular atrial fibrillation (NVAF) are at a high risk of gastrointestinal (GI) bleeding due to conditions including older age; stage III to V chronic kidney disease (CKD); HAS-BLED (hypertension, kidney or liver disease, stroke history, prior bleeding, unstable int...

Descripción completa

Detalles Bibliográficos
Autores principales: Lip, Gregory Y. H., Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin, Deitelzweig, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369361/
https://www.ncbi.nlm.nih.gov/pubmed/34398204
http://dx.doi.org/10.1001/jamanetworkopen.2021.20064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369361/
https://www.ncbi.nlm.nih.gov/pubmed/34398204
http://dx.doi.org/10.1001/jamanetworkopen.2021.20064

Ejemplares similares